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The damaging effects on cutaneous immunity of low-dose ultraviolet B (UVB) radiation in sunlight are genetically
determined in mice. Polymorphic alleles at the Tnfa and Lps loci dictate whether mice are UVB susceptible or
resistant, i.e., develop contact hypersensitivity or not when hapten is painted on UVB-exposed skin. In mice, UVB
susceptibility is mediated almost exclusively by tumor necrosis factor-alpha (TNFa). Circumstantial evidence
implicates urocanic acid (UCA) in the stratum corneum as the photoreceptor for UVB, and recent results suggest
that cis-UCA in turn instigates the intraepidermal accumulation of TNFa. It is hypothesized that TNFa interrupts the
induction of contact hypersensitivity by preventing epidermal Langerhans cells from carrying hapten to the draining
lymph node, where activation of naive, hapten-specific T cells must first occur. The phenotypic traits of UVB
susceptibility (UVB-S) and UVB resistance (UVB-R) have now been documented in human beings, and the frequency
of UVB-S is high (approximately 40–45%) in both Caucasians and individuals with deeply pigmented skin. Because the
frequency of UVB-S is extremely high in patients with biopsy-proved basal and squamous cell skin cancer, this trait
appears to be a risk factor for this disease. The unexpectedly high frequency of UVB-S in human beings, including
black-skinned persons, implies that the trait is not perceived by evolutionary processes as deleterious. The possible
selective advantages conferred by alleles that determine UVB-S are discussed with respect to cutaneous infections
in which mortality and morbidity are primarily mediated by immunopathogenic processes. J Invest Dermatol
100:47S–52S, 1993
It is a paradox that although solar radiation is essential for life, its
content of ultraviolet (UV) radiation constitutes a significant
hazard to many living forms. The skin and the eye are organ
systems that are exposed to solar radiation, and consequently are
particularly at risk of UV-induced damage. The range of UV-light-
induced disorders of the skin and the eye is broad, but ill-defined.
It is widely recognized that an important deleterious effect of UV
radiation within natural sunlight is to affect the cells of the
epidermis, leading eventually to the development of cutaneous
neoplasms. Epidemiologic evidence collected more than two
decades ago unequivocally implicated ultraviolet B (UVB)
radiation as a risk factor for basal and squamous cell cancers,
and more recent studies have revealed that UV radiation also
plays an important pathogenic role in certain types of malignant
melanoma. Moreover, there is considerable alarm, among
environmentalists, climatologists, and people concerned with
public policy, that as the ozone layer of the atmosphere is
progressively disrupted by people’s polluting activities, the
deleterious effects of UV light will be amplified in the near and
distant future. Despite the serious damaging effects of UV light
on skin and on the eye, its importance for dermatologists is not
limited to defining and avoiding its consequences. UV light has
been used for many years by dermatologists as a therapeutic
modality for a wide range of inflammatory and malignant
dermatoses. Consequently, experimental efforts to achieve a
proper understanding of the pathobiologic effects of UV light on
skin are important and relevant to both the prevention and
therapy of human skin diseases.
UVB AS A PERTURBANT OF THE CUTANEOUS
IMMUNE SYSTEM
Kripke and Daynes and their various collaborators [1,2] were the
first to appreciate (almost 20 years ago) that when UVB light was
delivered to the shaved, but intact skin of mice it could produce
profound and unexpected changes in the immune system. First, it
was demonstrated that chronically exposed animals eventually
developed cutaneous tumors. Then, it was demonstrated that the
cutaneous tumors induced by UVB radiation were highly
immunogenic. Most importantly, these investigators demon-
strated that normal mice were readily capable of rejecting
UVB-induced, syn-geneic tumors, whereas UVB-exposed mice
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were incapable of mounting an effective anti-tumor immune
response. Among the immunologic defects found in chronically
UVB-radiated mice were (a) a deficiency of conventional antigen-
presenting cells in the spleen and (b) populations of suppressor
T cells that selectively impaired anti-tumor immunity. In addition,
the antigen-presenting cell defect, combined with the suppressor
cell abnormality, robbed UVB-exposed mice of the capacity to
develop contact hypersensitivity (CH) to haptens applied to the skin
(irradiated or shielded from irradiation). Curiously, these immune-
impaired mice retained the capacity to mediate other forms of
immunity, such as responses to infectious agents and rejection of
skin allografts. More recently, similar immune abnormalities have
been described in mice exposed to a single, large dose of UVB
radiation. Experimental analysis of the systemic consequences of
chronic, as well as acute, high-dose UVB radiation, has been
pursued vigorously by Kripke and her colleagues, and the rich store
of information that has accrued is both extensive and important.
Just over a decade ago, Paul Bergstresser, who had recently
joined Jim Gilliam in the Department of Dermatology at Dallas,
and I became interested in the role of epidermal Langerhans cells
(LC) as the putative ‘‘antigen-presenting cells of the skin.’’ The
proposal that LC played this key immunologic role was already
formulated by Stingl et al [3] based on illuminating in vitro
analyses of epidermal cell suspensions enriched for Langerhans
cells. Our interests in Langerhans cells were particularly focused
by a (then) recent description of a proposed specialization of the
immune system, skin-associated lymphoid tissues (SALT), which
was envisioned to provide the skin with a distinctive and
appropriate set of immune effector modalities, sufficient to meet
the immunologic needs of the tissue to ward off environmental
threats, yet compatible with, and not disruptive of, skin’s
physiologic functions [4]. The original formulation of SALT,
which was modeled after GALT (gut-associated lymphoid tissues),
had a requirement for a population of ‘‘professional’’ antigen-
presenting cells that was expected to be located within the
parenchyma of the skin. Epidermal LC represented ideal
candidates. One strategy that Bergstresser and I used to study
an in vivo antigen-presenting role for LC was to expose the
shaved skin of mice and hamsters to an acute, low-dose regimen
of UVB radiation. This regimen (four daily doses of 40mJ/cm2)
was devised because it drastically reduced the density of normal
appearing LC within the irradiated site, but did not influence cells
at distant sites. To our delight (and relief), when an immunogenic
dose of the highly reactive hapten dinitrofluorobenzene (DNFB)
was painted on skin of C57BL/6 mice exposed to UVB in this
manner, CH was not induced [5]. These results were accepted as
strong circumstantial evidence in favor of the hypothesis that LC
were the essential antigen-presenting cells in CH induction, and
this evidence helped to strengthen the notion that the concept of
SALT is relevant to an understanding of cutaneous immunity.
Subsequent studies by Ma-catonia et al [6], Munn et al [7],
and Bigby et al [8] have confirmed that epidermal LC become
derivatized when haptens are applied epicutaneously, and that
the derivatized cells quickly (within a few hours) migrate out of
the epidermis, passing through the lymphatics to the draining
node. The hapten-bearing cells come to rest in the cortex, and it is
at this site that the first encounter with unprimed T cells, leading
to sensitization, takes place. Thus, in the induction of CH, the
antigen-presenting cell (LC) encounters antigen at one site
(epidermis) and encounters the T cells that will be sensitized at
another site (lymph node).
During the series of experiments exploring the effects of acute,
low-dose UVB radiation on induction of CH, we were delighted
(and surprised) to discover that mice that received dinitrofluor-
oben-zine (DNFB) on UVB-exposed skin not only failed to
develop CH, but were rendered immunologically tolerant of the
hapten [5]! This provocative result led to many additional
experiments from which it was eventually learned that tolerance
induced through UVB-treated skin is hapten specific and
mediated in part by suppressor T cells. When dendritic epidermal
T cells (DETC) were discovered [9,10], it was quickly determined
that hapten-derivatized DETC could induce hapten-specific
tolerance [11], raising the interesting possibility that DETC
might be UVB resistant and, therefore, following epicutaneous
hapten application, might become derivatized and able to carry a
tolerogenic signal to the immune system. However, to the
present, the cellular mechanisms of tolerance induction following
acute, low-dose UVB radiation remain elusive.
It is worthwhile at this point to digress in order to mention that
the finding that hapten-specific tolerance could be induced by
painting hapten on UVB-exposed skin provided the Dallas group
of immunologists and dermatologists an extraordinarily rich
source of challenges, new ideas, and experimental possibilities,
and this observation fueled many of the important experiments
conducted during the next several years. Jim Gilliam was party to
these exciting discussions, and his intellectual contributions and
wisdom were critical in formulating the design of that next
generation of experiments.
IMMUNOGENETIC BASIS OF THE EFFECTS OF UVB
ON CONTACT HYPERSENSITIVITY IN MICE
As our group and others began to explore the cellular bases for
the effects of acute, low-dose UVB radiation on induction of CH,
it was soon appreciated that this regimen of UVB radiation did not
impair CH induction in all inbred strains of mice. For example,
when DNFB was painted on the skin of BALB/c mice that
received four consecutive treatments with UVB, the mice
developed vigorous CH. Upon further study it was learned that
some genetically defined strains of mice are ‘‘unperturbed’’ by an
acute, low-dose regimen of UVB radiation to the epidermis, and
these mice develop CH as intense as though the hapten had been
applied to unirradiated skin [12]. Over the past 4 years, we have
characterized the effects of UVB radiation on CH induction in
numerous inbred mouse strains and their appropriate F, hybrids in
order to describe the range of this genetic effect [13]. A summary
of pertinent strains and F, hybrids is presented in Table I. For ease
of discussion, mice that develop intense CH equally well whether
hapten is painted on UVB-exposed or unexposed skin have been
designated UVB-resistant (UVB-R); mice that develop CH when
hapten is painted on normal skin, but develop feeble or no CH
when hapten is painted on UVB-treated skin have been
designated UVB-susceptible (UVB-S). As the data indicate,
UVB-S is not a unique property of C57BL/6 mice, nor is UVB-R
only found among BALB/c mice. It would appear that UVB-S is a
dominantly inherited trait, since F, hybrids derived from UVB-R
and UVB-S parents proved to be UVB-S. The sub-strains of C3H
mice are particularly informative because the HeJ and HeN
substrains differ genetically only at a mutation within the locus
that encodes responsiveness to bacterial lipopolysacchari.de
(LPS). Therefore, the mutant allele (Lpsd) found in C3H/HeJ mice
is able to confer UVB-R on the otherwise UVB-S C3H/HeN strain.
Since the F1 hybrid is also UVB-S, the Lps
d allele can confer
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resistance to UVB when present in the homozygous state. Han
et al [14] have shown that the macrophages of mice that contain
one or two copies of the Lpsd allele respond to LPS by massively
upregulat-ing the production of certain cytokines—IL-1, IL-6, and
TNFa. The primary, although not exclusive, molecular mechan-
ism of up-regulation is stabilization of the mRNA for these
cytokines. Recent evidence indicates that UVB radiation induces
secretion of all three of these cytokines by cultured keratinocytes,
and therefore the possibility exists that UVB-induced up-regula-
tion of IL-1, IL-6, and/or TNFa may interact with the Lpsn allele to
further amplify cytokine secretion within the epidermis. As
discussed below, recent data implicate TNFa as the pertinent
cytokine in mediating the deleterious effects of UVB on CH
induction in UVB-S mice.
Among the mouse strains possessing the Lpsn allele, UVB-R
correlates with strains that possess the D end of H-2 [murine
major histocompatibility complex (MHC)], suggesting that an-
other locus that governs UVB-R resides within the MHC. Fine
mapping of the H-2 chromosome between H-2S and H-2D has
been accomplished by determining whether appropriate recom-
binant inbred strains of mice develop CH when DNFB is painted
on UVB-treated skin. The results, also presented in Table I,
indicate that the only intra-H-2 locus that correlates perfectly with
UVB-S is Tnfa. Mice that are homozygous for Tnfad are uniformly
UVB-R, whereas all other mice, representing Tnfab,k,s,q,f alleles,
are UVB-S. Moreover, mice that are heterozygous for Tnfad are
also UVB-S. Thus, the U VB-resistance alleles Tnfad and Lpsd only
confer phenotypic resistance if present in the homozygous state.
These experiments reveal (a) that susceptibility to the
deleterious effects of UVB on induction of CH in mice is a
genetically determined trait, (b) that the trait is polygenic in
origin, and (c) that the trait is governed by polymorphic alleles at
the Tnfa and Lps loci. Resistance to the effects of UVB in this
system is a recessive trait and can be conferred by homozygosity
at either the Tnfa or Lps locus.
IDENTIFICATION OF TNFa AS THE PRIMARY
MEDIATOR OF UVB-SUSCEPTIBILITY
The genetic evidence cited above points directly at tumor
necrosis factor-alpha (a) as a candidate cytokine to mediate the
effects of UVB on CH induction. Pertinent to this issue, it has been
reported recently [15] that intradermal (ID) injections of
nanogram quantities of recombinant murine (rm) TNFa are non-
inflammatory, yet can alter LC in the overlying epidermis: the
density of class II MHC-positive cells in the epidermis is reduced
(approximately 30%), and the cells that remain either have no
dendrites, or only rudimentary ones, suggesting that the dendrites
have been retracted. The cell bodies are considerably more
rounded than typical LC. The possibility that changes in
epidermal LC may be pertinent to the induction of CH has been
tested directly (a) by injecting TNFa (50 ng) ID into skin
subsequently painted with hapten, and (b) by administering
neutralizing anti-TNFa antibodies systemically to mice whose
skin was UVB irradiated and painted with DNFB. These
experiments have been reported elsewhere [13,15,16]. As the
results summarized in Table II indicate, ID-injected TNFa
profoundly impairs CH induction in mice. Moreover, it has been
reported that the efficacy of TNFa in this regard is dependent
upon the genetic constitution of the mice, because much smaller
amounts of ID-injected TNFa were required to impair CH
induction in UVB-S mice than in UVB-R mice. The ability of
anti-TNFa antibodies to restore CH induction in UVB-S mice
exposed to UVB plus hapten confirms that TNFa is the primary (if
not the only) mediator of the deleterious effect of UVB on CH
induction.
We have recently conducted a series of in vitro studies aimed
at determining the consequences (if any) of TNFa on antigen-
processing and -presenting properties of epidermal Langerhans
cells. These experiments are based on the hypothesis that a TNFa-
dependent alteration of LC accounts for failed CH development in
UVB-S mice. Fresh and cultured LC have been treated with TNFa
and then used as accessory and antigen-presenting cells for
primed and alloreactive T cells (data not shown). Although the
Table I. Correlation of UVB-Susceptibility with
Pertinent Murine Genetic Loci
H-2
Strain Background UVB I-E Tnfa D Lps
C57BL/6 B6 S b b b n
BALB/c BALB/c R d d d n
(B6BALB)F1 B6/BALB S b/d b/d b/d n
C3H/HeN C3H S K k k n
C3H/HeJ C3H R k k k d
(HeNHeJ)F1 C3H S k k k n/d
(HeJB6)F1 B6/C3H S k/b k/b k/b n/d
B10.A B10 R k d d n
B10.BR B10 S k k k n
B10.A(2R) B10 R k d d n
B10.S B10 S s s s n
B10.M B10 S f f f n
Table II. Effects of UVB, TNFa, and cis-UCA on









None  Unchanged +++
None + Unchanged +++
UVB  Reduced 
UVB + Unchanged +++
TNFa  Reduced 
cis-UCA  Reduced 
cis-UCA + Unchanged +++
trans-UCA  Unchanged +++
aUVB-S mice (C57BL/6, C3H/HeN) were sensitized with 125 mg DNFB on
shaved abdominal skin treated as indicated prior to hapten application.
Some animals received an intraperitoneal injection of neutralizing anti-
TNFa antibodies prior to skin treatment. Epidermal Ia+ Langerhans cells
were enumerated in skin 2–5h after skin treatment and prior to hapten
application. All mice were ear challenged with 40 mg DNFB 5 d after
hapten application to determine induction of contact hypersensitivity.
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entire set of experiments has not yet been completed, we have
found no evidence for reduced antigen processing, presentation,
or T-cell activation by TNFa-treated LC. If confirmed, these results
suggest that if TNFa is the agent responsible for the UVB-induced
effects, it does not prevent CH induction by interfering with the
ability of LC to process or present hapten to T cells. However,
another line of investigation has been more informative.
In normal skin, the density of normal-appearing LC at a site of
epicutaneous application of hapten falls dramatically within a
few hours, and by 24h less than 50% of the original density of LC
remains at the site. Combined with the evidence that hapten-
bear-ing LC arrive at the draining lymph node within 6–24 h of
epicutaneous hapten painting, the depletion of epidermal LC after
hapten painting is consistent with the hypothesis that CH
induction depends upon prompt emigration of hapten-bearing
LC from the painted site. Because of the morphologic effects of
TNFa on LC described above—which suggested that TNFa
induced major alterations in the cytoskeleton of the LC—we
wondered whether TNFa might prevent CH induction by
immobilizing LC at the hapten application site. To test this
possibility, TNFa was injected ID into sites over which the
epidermis was subsequently painted with a sensitizing dose of
DNFB. When the density of LC was determined 24h later most, if
not all, LC were still present [16,17]. By contrast, the density of
LC at cutaneous sites painted with hapten following ID injection
of PBS was markedly reduced at 24 h. These data support the
contention that TNFa inhibits the mobility of epidermal LC, at
least temporarily, and this immobilization may be sufficient to
abort the induction of CH. Our future studies will test this idea.
Although the evidence cited above points to TNFa as the
primary mediator of UVB effects on CH induction, the data do not
suggest a molecular mechanism that would link UVB radiation
with TNFa production in the skin. To that end, it is known that the
epidermis, especially the stratum corneum, contains large
amounts of trans-urocanic acid (t-UCA). When skin is exposed
to UVB radiation, a significant amount of this compound is
converted into the cis form (c-UCA). Thus, trans-UCA is a
photoreceptor for UVB (although many other molecules in the
skin can also be placed in this category). De Fabo et al [18] have
provided strong circumstantial evidence that urocanic acid (UCA)
is the critical epidermal photoreceptor for UVB radiation, at least
with respect to the effects of chronic or high-dose UVB radiation
on systemic immunity. In addition, they have reported that
systemic administration of cis-UCA produces a deficient immune
response similar to that achieved by high-dose UVB radiation.
Ross et al [19] have found that ID-injected cis-UCA impairs the
induction of herpes simplex virus -specific delayed hypersensi-
tivity in mice if the virus is also injected into the skin. Using these
observations as leads, we have now examined the putative
relationships among cis-UCA, UVB, and TNFa in the impairment
of CH induction in U VB-S mice. Using a strategy similar to that
described above for TNFa, we have determined that ID-injected
cis-UCA (but not t-UCA) altered the local LC density and
morphology in a manner similar to TNFa and low-dose UVB
radiation (Table II). Moreover, hapten painted on skin that
received an ID injection of cis-UCA 5h previously failed to
induce CH. Most important to our experimental analysis,
systemic administration of a single dose of neutralizing anti-
TNFa antibodies immediately after the ID injection of cis-UCA
and prior to epicutaneous painting with hapten abolished the
deleterious effects of cis-UCA on CH induction, and reversed the
cis-UCA—induced alterations in LC morphology. Thus, cis-UCA
produces effects on LC and CH induction that are strikingly
similar to TNFa and UVB radiation, and because anti-TNFa
antibodies neutralize the effects of cis-UCA, TNFa, and UVB, we
believe that the three agents are patho-physiologically linked.
The findings summarized to this point have led us to speculate
on the pathophysiologic effects of UVB radiation on the induction
of CH in UVB-S mice. As an initial event, UVB radiation converts
trans- to cis-UCA in the stratum corneum. Directly, or indirectly,
cis-UCA then induces the accumulation of TNFa within the
epidermis (presumably by activating the appropriate Tnfa and Lps
alleles within keratinocytes). TNFa in turn acts on LC, perhaps by
disrupting or altering the cytoskeleton and, as a consequence, the
cells are unable to move. Because in the induction of CH, hapten-
bearing LC must escape from the epidermis and reach the
draining node within 24 h in order for T cells to be activated,
TNFa-dependent immobilization of LC within the hapten-painted
epidermis is sufficient to prevent sensitization, and permits the
tolerogenic signal (that is also generated in UVB-exposed,
hapten-painted skin) to reach the immune system first.
UVB SUSCEPTIBILITY AND RESISTANCE IN HUMANS
Lest impressions arise that studies of CH in mice and of the
influence of UVB radiation are the esoteric concerns of basic
scientists, efforts have been made over the past five years
to determine whether UVB-S and UVB-R are phenotypic traits
in humans and, if so, whether these traits are relevant to
dermatologic diseases. A protocol was devised [20], similar to
that used in mice, in which human buttock skin received four
daily exposures (at 144mJ/cm2) of UVB. Immediately after the last
exposure, a universally sensitizing dose of dinitrochlorobenzene
(DNCB, 2000mg) was applied to the irradiated site. Thereafter,
the site was assessed for development of primary allergic reaction
(PAR) and after 30 d the volar surface of the forearm was
challenged with dilute dinitrochlorobenzene (DNCB) to detect
CH. A variety of subjects have been subjected to this protocol:
healthy Caucasian and black-skinned adults, patients with
biopsy-proved basal and/or squamous cell skin cancer, and age-
matched healthy controls [21,22]. A summary of results is
displayed in Table III. The first important result to note is that a
significant proportion (40–45%) of healthy adults failed to
develop CH when DNCB is painted on UVB-exposed skin, i.e.,
they are UVB-S. Thus, UVB-S and -R appear to be polymorphic
traits in humans as well as mice. Second, the UVB-R and UVB-S
pheno-types occur in subjects with deeply pigmented skin,
Table III. Influence of UVB Radiation on Induction of






Caucasian 12 No 100
Caucasian 63 Yes 56
Deeply pigmented 6 No 100
Deeply pigmented 25 Yes 52
Skin cancer 25 Yes 9
Caucasian450 13 Yes 57
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whether secondary to tanning or genetic predisposition. More-
over, the frequencies of the UVB-S and UVB-R traits are very
similar in black-skinned persons and in Caucasians. Therefore, it
does not appear that either the amount or the type of melanin
within the epidermis can influence the capacity of UVB to impair
induction of CH. Third, very few patients with biopsy-proved skin
cancer develop CH when DNCB is painted on UVB-exposed
skin, i.e., almost all are UVB-S, even though the frequencies of
UVB-S and UVB-R in age-matched older healthy Caucasians
are virtually identical to that of young healthy adults. Thus, there
is an enrichment for the UVB-S trait among patients with skin
cancer, and this enrichment implies that this trait is a risk factor
for skin cancer.
Because UVB-S subjects displayed no evidence of hapten-
specific CH, it was possible to test whether their initial experience
with hapten via UVB-treated skin induced hapten-specific
immunologic tolerance. At the completion of the UVB-exposure
protocol described previously, UVB-S subjects received a second
sensitizing dose of DNCB on buttock skin that had not been
exposed to UVB. These subjects were then examined for PAR
development and for CH expression by challenge with hapten on
forearm skin. The results of studies carried out in UVB-S healthy
Caucasians, healthy black-skinned individuals, and patients with
a history of skin cancer have been reported elsewhere [21,22].
A small percent of healthy UVB-S subjects, both Caucasian and
deeply pigmented, failed to develop CH. However, a much larger
fraction of the skin-cancer patients proved to be unresponsive to
DNCB in this study. To determine whether the failure to develop
CH to DNCB in these individuals was hapten-specific, each
unresponsive subject subsequently received an epicutaneous
sensitizing dose of diphencyprone (DPCP, 500mg), a non-cross-
reactive hapten. In every instance, including the older skin cancer
patients, CH to DPCP was detected in these subjects. Thus, the
unresponsiveness to DNCB displayed by some of the UVB-S
subjects that received a second sensitizing dose of this hapten
appears to be true immunologic tolerance, rather than non-
specific unresponsiveness. Because significantly more skin-
cancer patients displayed tolerance of this type than did healthy
UVB-S subjects, and because the incidence of tolerance
among skin-cancer patients is considerably less than the
incidence of the UVB-S trait, hapten-specific tolerance induced
by UVB may be a second, independent risk factor for skin cancer.
We suspect that its induction may involve (at least partially)
different mechanisms and genes from those that promote the
UVB-S trait.
ON THE IMMUNOLOGIC AND BIOLOGIC
MEANING(S) OF UVB-S
It is apparent that UVB radiation in sunlight triggers a complex set
of intraepidermal (and dermal) changes that are mediated by
TNFa. Although our knowledge of the molecular links between
UVB radiation and accumulation (or secretion) of TNFa in the
epidermis is incomplete, strong circumstantial evidence supports
trans-UCA as the relevant epidermal photoreceptor that is
modified by UVB and triggers the TNFa response. We and others
have documented some highly interesting intraepidermal and
systemic changes that are mediated by TNFa, including altera-
tions in LC, impairment of induction of hapten-induced CH, and
instigation of cutaneous tumors. However, we are circumspect
about concluding that the ‘‘message’’ that TNFa mediates concerns
susceptibility to skin cancer. Some of our reasons follow.
The evidence that UVB-S in mice is dictated by specific alleles
at two independent loci (Tnfa and Lps) suggests that the UVB-S
and UVB-R traits that we have defined in humans may be under
similar genetic control. However, at the present, insufficient
evidence exists to verify that suggestion. But if it turns out that
UVB-S and UVB-R are genetically controlled in humans, several
complications arise as to the meaning of the existence of these
traits in the human population. We have proposed that UVB-S is a
risk factor for skin cancer, at least of the basal and squamous cell
types. If so, then the alleles encoding the UVB-S trait must be
considered to have a deleterious effect when they interact with
UVB radiation. Because UVB radiation is ubiquitous, then these
same alleles must be considered as universally deleterious.
Consequently, evolutionary pressures should have selected^or
the alleles that produce the UVB-R pheno-type, and against the
alleles that produce the UVB-S phenotype. Yet, the frequency of
the UVB-S trait is very high in the human populations we have
studied—it is found in 35–45% of individuals. Clearly, selection
has not eliminated the genes responsible for UVB-S. Based on
these and other considerations, one can argue that the deleterious
effects of the UVB-S—determining alleles (increase the risk for
skin cancer) are irrelevant to selective pressures because skin
cancer is a disease of individuals who are usually beyond their
reproductively effective years; moreover, skin cancer is less life
threatening than many other forms of cancer. Thus, the UVB-S
and UVB-R phenotypes (and presumed genotypes) exist in the
human population as a balanced polymorphism, but the reasons
for the balance are obscure.
The second theoretical complication that arises from the
results of our studies of UVB-S in humans is that UVB-S exists
among black-skinned subjects, and the frequency of UVB-S is
virtually the same in Blacks and Caucasians. Until recently, it has
been widely believed that melanin, which is itself an important
photoreceptor for UVB radiation, protects against the damaging
effects of UVB light that lead to skin cancer [23]. Because a
failure of the immune system is considered to contribute to the
emergence of cutaneous cancers, it was expected that melanin
would also protect against the damaging effects of UVB on
cutaneous immunity. Studies in mice are not helpful: except in
skin experiencing active hair growth, interfollicular epidermis of
rodent skin is devoid of melanin. Therefore, studies of the effects
of UVB on CH in rodents do not test a role for melanin in
protecting the skin immune system against UVB. By contrast, our
studies in humans unequivocally demonstrate that epidermal
melanin content or type plays no role in determining whether an
individual is UVB-S or UVB-R [22]. In fact, the frequency of the
UVB-S trait is approximately the same among deeply pigmented
individuals as among Caucasians. This finding immediately raises
questions about the ‘‘true’’ physiologic role of the genes that
create the UVB-S trait. Perhaps the studies of Howie et al [24]
provide insight into this issue, because their evidence indicates
that UVB radiation can interfere with the induction of delayed
hypersensitivity to the herpes simplex virus-1. In a similar line of
inquiry, Giannini et al [25] have demonstrated that a lethal form
of murine cutaneous leishmaniasis can be converted to a more
symbiotic infestation by exposure of mice to UVB radiation.
Lethality in this form of experimental leishmaniasis is largely
dictated by an inappropriately vicious immune response against
parasite-associated antigens, so vicious that the animals die of
debilitation secondary to severe and non-specific damage to the
skin. Thus, death in this instance is immunopathogenic in origin,
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i.e., the consequences of an inappropriately aggressive and
indiscriminate cell-mediated immune response to antigens
derived from cutaneous pathogens. Both the HSV-1 studies and
the leishmaniasis studies raise the possibility that UVB light might
have an unexpectedly protective role to play in host-parasite
relationships. Specifically, the data indicate that the ability of
UVB radiation to suppress cell-mediated immunity to cutaneous
antigens may prevent the host from mounting an immune
response directed at pathogenic antigens that, in its vigor, is
actually deleterious to the host. One might even speculate that
the presence of genes that promote the UVB-S phenotype in
human populations might be beneficial to preservation of the
species, and therefore that selective pressures would retain the
relevant alleles at a high frequency. Many cutaneous parasitic
infestations occur in the tropics where native populations have
deeply pigmented skin. The inability of melanin to prevent
the deleterious effects of UVB on cutaneous immunity makes
sense if UVB-induced immune suppression is needed to protect
human beings from the immune-mediated diseases associated
with parasitic infections. Even in human populations with poorly
pigmented skin, UVB-S may have a protective, rather than a
deleterious, role in human biology. The interaction between UVB
radiation and cutaneous infections with HSV-1 may be but one
example of this possibility.
I deeply appreciate my numerous senior collaborators over the years, especially R. E. Billingham,
Paul R. Bergstresser, and]. Richard Taylor, and I am indebted to the numerous pre- and post-
doctoral trainees whose thoughts and labors have been essential to the success of this line of
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